Michael Schmidt

Chief Scientific Officer, Alloy Therapeutics

Cambridge, Massachusetts

About

Male

Michael Schmidt is the Chief Scientific Officer of Alloy Therapeutics. He previously worked at Ankyra Therapeutics as a Chief Scientific Officer. Michael Schmidt attended Massachusetts Institute of Technology.

Experience

Alloy Therapeutics

Chief Scientific Officer

View →

Growth134Waltham, Massachusetts, United StatesBiotech/Pharma · Biopharma

Chief Scientific Officer · Ankyra

Education

Massachusetts Institute of Technology · PhD, Biological Engineering
2004 – 2009
Villanova University · BS, Biology
2000 – 2004

Headlines from Google News. Social posts load from the platform only when you open a tab.

Chutes & Ladders—AbbVie's president tacks on COO responsibilities
fiercebiotech.com · Jun 30
Alloy Therapeutics Expands Executive Team
citybiz.co · Jun 29

People at Alloy Therapeutics

Christian Cobaugh

Chief Executive Officer of Genetic Medicines Division

Errik Anderson

Founder and CEO

Alaa Halawa

Data from: crunchbase